Lab reference
ESR
What the research found.
The usual age-adjusted normal limit for the sedimentation rate has two forms. For men, take your age and halve it. For women, add ten to your age first and then halve it, which is the half most labs leave off the report.
Without the age rule, 85 percent of older-onset rheumatoid arthritis patients was above the normal limit, against 71 percent of younger-onset patients. Apply the age rule and the figures become 65 and 68 percent. The apparent difference between the two groups vanishes.
Ranganath and colleagues, Journal of Rheumatology, 2005
Two rheumatoid arthritis databases covered twenty-five years of patients between them. In 33 to 42 percent of those patients, both the sedimentation rate and C-reactive protein read normal at the first recorded measurement. That is a large minority of people with real disease and unremarkable bloods.
For spotting giant cell arteritis, the sedimentation rate caught 48 percent of cases and cleared 72 percent of the people who didn't have it. C-reactive protein caught 74 percent and cleared 49 percent. So each one misses what the other catches, which is why both get ordered.
What the number means.
| Band | Value | What it means | Source |
|---|---|---|---|
| Usual normal limit, men | Your age divided by two | An age rule by habit rather than a checked target. | Ranganath 2005 |
| Usual normal limit, women | Your age plus ten, divided by two | The same rule, ten points higher. | Ranganath 2005 |
| Older-onset rheumatoid arthritis, no age rule | 85 percent above the limit | Age alone pushes most older patients over the line. In younger-onset patients it was 71 percent. | Ranganath 2005 |
| Active rheumatoid arthritis, normal markers | 33 to 42 percent | Both this and C-reactive protein read normal in that many patients. So a normal result doesn't rule out active disease. | Sokka 2009 |
| Spotting giant cell arteritis | Caught 48 percent. Cleared 72 percent. | So it misses about half of a diagnosis that can cost your sight. | Currier 2025 |
| A treatment target on its own | Not checked | It falls inside combined disease scores. It isn't aimed at on its own. | No source, because no target is set |
A reference range is not a target. Where a range on this page differs from the one your laboratory prints, the difference is explained above and sourced below. Where no trial has tested a target, this page says so rather than offering one.
What the test measures
The erythrocyte sedimentation rate is one of the oldest tests still in routine use, and the method is almost mechanical. Blood goes into a vertical tube and is for an hour, and then somebody measures how far the red cells have fallen, in millimeters. Red cells sink faster when they stick to each other, and they stick more readily when your blood is rich in the proteins that inflammation produces, the main one being fibrinogen.
So the test doesn't measure inflammation directly, it measures a physical result of the protein changes that inflammation causes. That's why it responds slowly, and it's why so many unrelated things move it. The simplicity is real, and so is the vagueness.
Why age changes the answer
The sedimentation rate rises as people get older, even in people with no inflammatory disease at all, so one upper limit for everybody calls older people abnormal when they aren't. The usual correction has two forms, where for men it's your age divided by two and for women it's your age plus ten, divided by two. Ask whether your own lab applies it, because many report one range for everybody.
One study showed how much difference that makes. It compared older-onset with younger-onset rheumatoid arthritis, and without the age rule, 85 percent of the older group was above the limit against 71 percent of the younger group, which looks like a real difference in how much inflammation each group had. Then the researchers applied the age rule, the figures became 65 and 68 percent, and the apparent difference vanished.
What had looked like a feature of older-onset disease was a feature of the reference range. Here is what that means if you're reading your own result. A sedimentation rate of 35 means one thing at seventy-five and something else at twenty-five, and a lab report using one cut-off for all ages won't tell you that, so ask whoever ordered the test which limit they read it against.
What a normal result doesn't rule out
Two databases of consecutive rheumatoid arthritis patients covered 1980 to 2004, recording what the inflammation markers looked like when patients first turned up. Both the sedimentation rate and C-reactive protein read normal in 33 percent of one group and 42 percent of the other. All three of the sedimentation rate, CRP, and rheumatoid factor read normal in 15 and 14 percent, and all three read abnormal in only 28 and 23 percent.
That's the single most useful thing to know about this test. A large minority of people with real rheumatoid arthritis have unremarkable markers when they first present, so being told your bloods are fine isn't the same as being told nothing is wrong. Swollen, stiff joints with normal markers still need a rheumatology assessment.
That holds in more urgent settings too. In one series of 130 patients with giant cell arteritis, 23 had a normal sedimentation rate and a normal CRP, and the ones measured longer after their symptoms began were more likely to look normal. So in that illness the symptoms lead and the tests follow behind them.
How it compares with CRP
The two markers work together rather than compete, and knowing the difference helps you read your own results. Your liver makes CRP within hours of an inflammation signal and clears it just as fast, so CRP shows the present. The sedimentation rate depends on protein changes that take days to build and days to settle, so it trails behind how you feel, in both directions.
That lag has a practical result. A sedimentation rate drawn while a flare is settling can still read high when you're already improving, and one drawn early in a flare may not have caught up yet. CRP tracks much closer to what's happening on the day it was taken.
The two also perform differently. For giant cell arteritis, CRP caught 74 percent of cases and cleared 49 percent of healthy people, while the sedimentation rate caught 48 percent and cleared 72 percent. So CRP catches more cases and raises more false alarms, the sedimentation rate does the reverse, and ordering both is the usual approach because neither is good enough alone.
Where it's still used
The sedimentation rate survives in rheumatology for concrete reasons. The DAS-28, a score built from a 28-joint count, a blood marker, and your own health rating, is the combined score used to guide rheumatoid arthritis treatment, and it comes in two forms built on one marker each. In polymyalgia rheumatica and giant cell arteritis it's part of how those diagnoses get made and followed.
What it isn't is a target of its own. Treatment in rheumatoid arthritis aims at a combined score rather than at any single marker, and that strategy is the one the trials support. So a sedimentation rate improving on its own, with your joints unchanged, isn't a treatment success.
What else raises it
The list is long, which is this test's main weakness. Low blood counts raise it, and so does pregnancy, and so does kidney disease, and so does any infection. Some cancers raise it a great deal, and simply being older raises it, as above.
Some things push it down in ways that can mislead you the other way. Anything that changes the form or number of your red cells can do it, with having too many red cells and having sickle cell disease as two examples. Very high white cell counts can interfere, and so can how the sample was handled, because this is a physical measurement made in a tube, and a delay before the sample gets run will change the answer.
So the upshot is straightforward. A sedimentation rate is worth reading alongside a clinical assessment and rarely worth reading alone. If a result doesn't match how you feel, that mismatch is a reason to ask about it rather than to accept the number, and repeating it or ordering a CRP alongside is a fair next step.
Questions patients ask.
My ESR is high. Does that mean I have an inflammatory disease?
Not on its own. The sedimentation rate rises with inflammation, and it also rises with age, with low blood counts, in pregnancy, with kidney disease, and with anything that raises the proteins in your blood. So it's a signal that something may be worth looking into, and not a diagnosis. One mildly raised result in somebody who feels well often turns out to mean nothing at all.
Why does my normal range depend on my age?
Because the sedimentation rate really does rise as people get older, so using one cut-off for everybody calls older people abnormal when they aren't. The usual rule has two forms. For men it's your age divided by two, and for women it's your age plus ten, divided by two. One study showed how much that counts, because an apparent difference between older-onset and younger-onset rheumatoid arthritis vanished entirely once the age rule was used.
My ESR is normal. Can I still have inflammatory arthritis?
Yes, and often. Two large rheumatoid arthritis databases recorded what the markers looked like at the first measurement, and in 33 to 42 percent of patients both the sedimentation rate and C-reactive protein read normal. In about 15 percent, all three of those plus rheumatoid factor read normal. So a normal result makes inflammation less likely without ruling it out, and what your doctor finds on examining you counts for more.
Which one is better, the ESR or the CRP?
Neither, because they answer slightly different questions. CRP rises and falls within hours, so it shows what's happening now, while the sedimentation rate changes over days to weeks and trails behind how you are. Age, sex, and low blood counts also move the sedimentation rate in ways they don't move CRP. In giant cell arteritis, CRP caught more cases while the sedimentation rate cleared more healthy people, which is why both usually get ordered.
Is the ESR used to follow my disease?
Yes, mostly inside a combined score rather than on its own. The DAS-28, a score built from a 28-joint count, a blood marker, and your own health rating, comes in two forms, one built on the sedimentation rate and one on CRP, and those scores are what treatment decisions rest on in rheumatoid arthritis. Remember the lag, though, because the sedimentation rate trails behind how you are, so a blood draw taken while a flare is settling can still read high when you're already getting better.
Can anything make my ESR falsely low?
Yes, and that's worth knowing if your result doesn't match how you feel. Anything that changes the form or the number of your red cells can push it down, with having too many red cells and having sickle cell disease as two examples. Very high white cell counts can interfere too, and so can how the sample was handled. So if a result doesn't fit your picture, ask for it again, and ordering a CRP alongside is fair too.
References.
- Ranganath VK; Elashoff DA; Khanna D et al. Age adjustment corrects for apparent differences in erythrocyte sedimentation rate and C-reactive protein values at the onset of seropositive rheumatoid arthritis in younger and older patients. The Journal of rheumatology. 2005;32:1040-2. PMID 15940764Observational cohort analysis of 263 patients with early seropositive RA enrolled within 14 months of symptom onset
- Sokka T; Pincus T. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35%-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. The Journal of rheumatology. 2009;36:1387-90. 10.3899/jrheum.080770Retrospective analysis of two consecutive usual-care RA databases
- Currier C; Bays A; Thomason J. Normal inflammatory markers in giant cell arteritis: a diagnostic blind spot. Rheumatology International. 2025;45. 10.1007/s00296-025-05930-3Retrospective diagnostic accuracy study within a single fast-track GCA clinic
This page gathers the published research on this subject into one place. The studies behind it were published between 1989 and 2026, and every figure links to the paper it came from. Those studies were peer reviewed. This summary of them was not. Dr. Sarah Luebker is reviewing these pages one at a time and has not reached this one yet, so it carries no medical review date and nothing here is her opinion or her advice to you. Each page gets updated as she reaches it. It is here in the meantime because the science is worth having in one organized place that is easy to find and easy to read. Talk to your own clinician before acting on any of it.